Lose weight and keep it off with diet, exercise and once-daily prescription Qsymia.1,2

Average results in adults 18 years and older after 56 weeks. View study design.

You want to achieve real, lasting weight loss

How similar is your journey? In a survey of 3,372 real Qsymia patients:
Over 50%

The top 3 life events leading to weight gain were:

  • Changes in metabolism
  • Stress or mental health
  • Demands of work and family life
Top 3

Indicated the reason they wanted to lose weight was to:

Become healthier and improve overall health

QSYMIA PATIENT SURVEY: Online survey conducted in August 2021. Responses from 3,372 Qsymia patients, 18 years or older. Respondents were not remunerated for participating in the survey.

You don’t have to try to lose weight on your own

Ask your doctor if prescription, once-daily Qsymia is right for you.
Choose from the following:

See the Real
Weight-Loss Results

Qsymia is clinically proven to help adult patients lose weight and inches off their waist.1,2

Qsymia Offers
Real Control

Qsymia can help you take control of the hunger and cravings you struggle with.1

Multiple Ways to
Save on Qsymia

Now it’s easier to get Qsymia, manage your plan and achieve your weight-loss goals!

The results presented here are from the combined studies supporting FDA approval of Qsymia. The dosing schedule in those studies differ from the dosing schedule that your physician may recommend. As a result of this dosing differential, your results may vary depending on your weight, BMI, diet, activity level, dose of Qsymia, and other factors.

Qsymia was studied in 2 large trials that involved 3,754 patients 18 years and older whose BMI was 27 kg/m2 or greater. For the subjects in the 2 studies the average baseline weight was 256 lbs and 227 lbs, and the average baseline waist circumference was 47 inches and 45 inches. Patients were randomized to placebo, phentermine 3.75 mg/topiramate 23 mg (starter dose), phentermine 7.5 mg/topiramate 46 mg (recommended dose), or phentermine 15 mg/topiramate 92 mg (top dose). In these trials, it was recommended that patients eat a well-balanced diet and reduce their caloric intake by 500 kcal/day.1,2


Qsymia is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management inadults with an initial body mass index (BMI)…

Important Safety Information

Do not take Qsymia if you are pregnant, planning to become pregnant, or become pregnant during Qsymia treatment; have glaucoma; have thyroid problems (hyperthyroidism); are taking certain medicines called monoamine oxidase inhibitors…


For adult patients with a body mass index (BMI) of 30+ or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related medical condition or pediatric patients aged 12 years and older with an initial BMI in the 95th percentile or greater standardized for age and sex.

QSYMIA® is now approved for more patients!

JULY 2022:

The FDA has approved the use of Qsymia in the treatment of obesity in children ages 12-17 with an initial body-mass index (BMI) in the 95th percentile or greater standardized for age and sex. This approval will provide an important option to pediatric patients struggling with the condition.